Wang, Shengdong <br/><br/>
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells   [electronic resource] 

 -  Frontiers in immunology  2018 
 - 377 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1664-3224 
<br/><br/><label>Standard No.: </label>10.3389/fimmu.2018.00377  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cytotoxicity, Immunologic<br/>Humans<br/>Immunotherapy--methods<br/>Lymphocyte Activation<br/>Mevalonic Acid--metabolism<br/>Osteosarcoma--drug therapy<br/>Receptors, Antigen, T-Cell, gamma-delta--metabolism<br/>Signal Transduction<br/>T-Lymphocytes--drug effects<br/>Valproic Acid--pharmacology<br/>Zoledronic Acid--pharmacology